Terumo (OTCMKTS:TRUMY) Announces Earnings Results

Terumo (OTCMKTS:TRUMYGet Free Report) released its quarterly earnings results on Friday. The company reported $0.11 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.11, Zacks reports. Terumo had a return on equity of 9.01% and a net margin of 11.74%.

Terumo Stock Up 4.1%

Shares of OTCMKTS TRUMY traded up $0.50 during trading hours on Friday, hitting $12.68. The company had a trading volume of 295,120 shares, compared to its average volume of 379,789. The stock has a market capitalization of $18.70 billion, a P/E ratio of 21.86 and a beta of 0.62. The company has a quick ratio of 0.89, a current ratio of 1.51 and a debt-to-equity ratio of 0.07. Terumo has a 1-year low of $12.08 and a 1-year high of $19.64. The firm’s 50 day moving average is $13.08 and its 200-day moving average is $14.01.

Analysts Set New Price Targets

A number of research firms have weighed in on TRUMY. Zacks Research raised Terumo to a “hold” rating in a research report on Thursday, April 9th. Nomura raised Terumo to a “hold” rating in a research report on Tuesday, February 24th. Two equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Hold”.

View Our Latest Analysis on TRUMY

Terumo Company Profile

(Get Free Report)

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.

Read More

Earnings History for Terumo (OTCMKTS:TRUMY)

Receive News & Ratings for Terumo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Terumo and related companies with MarketBeat.com's FREE daily email newsletter.